Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 3, Issue 1, 2024
  6. Article
Review Article Open Access January 30, 2024

Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions

Sourav Adak 1,*
1
New Jersey, United States
Publihed in: Current Research in Public Health (Volume 3, Issue 1, 2024)
Page(s): 10-14
DOI: 10.31586/ujpp.2024.996
Received
November 10, 2023
Revised
December 21, 2024
Accepted
January 28, 2024
Published
January 30, 2024
Keywords
Active Pharmaceutical Ingredients; Supply chain; Covid-19; Drug shortage; Production
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2024. Published by Scientific Publications
Article metrics
Views
502
Downloads
85

Cite This Article

APA Style
Adak, S. (2024). Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions. Current Research in Public Health, 3(1), 10-14. https://doi.org/10.31586/ujpp.2024.996
ACS Style
Adak, S. Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions. Current Research in Public Health 2024 3(1), 10-14. https://doi.org/10.31586/ujpp.2024.996
Chicago/Turabian Style
Adak, Sourav. 2024. "Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions". Current Research in Public Health 3, no. 1: 10-14. https://doi.org/10.31586/ujpp.2024.996
AMA Style
Adak S. Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions. Current Research in Public Health. 2024; 3(1):10-14. https://doi.org/10.31586/ujpp.2024.996 
@Article{crph996,
AUTHOR = {Adak, Sourav},
TITLE = {Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions},
JOURNAL = {Current Research in Public Health},
VOLUME = {3},
YEAR = {2024},
NUMBER = {1},
PAGES = {10-14},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/996},
ISSN = {2831-5162},
DOI = {10.31586/ujpp.2024.996},
ABSTRACT = {The operational performance of Active Pharmaceutical Ingredients (API) supply chains often suffers from significant disruptions attributed to inherent vulnerabilities. Despite theoretical discussions, empirical evidence validating these vulnerabilities remains sparse. This study endeavours to empirically substantiate the vulnerabilities arising from dynamic disruptions within the pharmaceutical supply chain. Its primary goal is to discern actionable insights that can inform the development of robust resilience strategies capable of effectively mitigating such disruptions. This study investigates vulnerabilities within the active pharmaceutical ingredient (API) supply chain in response to disruptions. Despite theoretical insights, empirical evidence validating these vulnerabilities remains limited. Through empirical analysis, this research aims to identify and elucidate the specific vulnerabilities exacerbated by dynamic disruptions in the API supply chain. The findings are intended to inform the development of resilient strategies capable of mitigating the impact of disruptions on pharmaceutical supply chains.},
}
%0 Journal Article
%A Adak, Sourav
%D 2024
%J Current Research in Public Health

%@ 2831-5162
%V 3
%N 1
%P 10-14

%T Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions
%M doi:10.31586/ujpp.2024.996
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/996

TY  - JOUR
AU  - Adak, Sourav
TI  - Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions
T2  - Current Research in Public Health
PY  - 2024
VL  - 3
IS  - 1
SN  - 2831-5162
SP  - 10
EP  - 14
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/996
AB  - The operational performance of Active Pharmaceutical Ingredients (API) supply chains often suffers from significant disruptions attributed to inherent vulnerabilities. Despite theoretical discussions, empirical evidence validating these vulnerabilities remains sparse. This study endeavours to empirically substantiate the vulnerabilities arising from dynamic disruptions within the pharmaceutical supply chain. Its primary goal is to discern actionable insights that can inform the development of robust resilience strategies capable of effectively mitigating such disruptions. This study investigates vulnerabilities within the active pharmaceutical ingredient (API) supply chain in response to disruptions. Despite theoretical insights, empirical evidence validating these vulnerabilities remains limited. Through empirical analysis, this research aims to identify and elucidate the specific vulnerabilities exacerbated by dynamic disruptions in the API supply chain. The findings are intended to inform the development of resilient strategies capable of mitigating the impact of disruptions on pharmaceutical supply chains.
DO  - Unveiling Vulnerabilities in the Active Pharmaceutical Ingredient Supply Chain Amid Disruptions
TI  - 10.31586/ujpp.2024.996
ER  -